<DOC>
	<DOCNO>NCT01724372</DOCNO>
	<brief_summary>This randomize , control pilot study compare antidepressant fluoxetine second generation antipsychotic aripiprazole approximately 10 subject age 12-25 risk develop psychosis . Our primary hypothesis compare aripiprazole , fluoxetine well tolerate lead great improvement symptom end 6 month treatment .</brief_summary>
	<brief_title>The Role Antidepressants Antipsychotics Preventing Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1225 year age ( inclusive ) Able understand speak English Have least one subthreshold positive psychotic symptom moderate , moderately severe , severe Lifetime diagnosis Axis I psychotic disorder : schizophreniform disorder ; schizophrenia ; schizoaffective disorder ; bipolar disorder ; major depression psychotic feature Current psychosis Current diagnosis Major Depressive Disorder , single episode recurrent , severe without psychotic feature Lifetime diagnosis substance abuse dependence ( exclude nicotine ) Current stimulant treatment Any significant medical condition contraindicate treatment either aripiprazole fluoxetine , include history neurological , neuroendocrine medical condition know affect brain Estimated intelligence quotient &lt; 70</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>